Digital health innovations
We are actively seeking proven digital innovations that improve the health of people in the region and raise the quality, efficiency, safety and cost-effectiveness of delivering healthcare.
We are particularly interested to hear about innovations in the following categories:
  • Health maintenance - supporting people in maintaining their physical and mental wellbeing,
  • Prevention - alerting patients, carers or professionals when there are signs that things aren’t going well, and an intervention can prevent crises or emergencies
  • Access - providing more convenient and cost-effective ways for patients and professionals to interact. (e.g. remote monitoring or virtual consultations).
  • Learning and education - delivering information and knowledge to patients about their health or condition, or to professionals to support their continuous professional development
  • Pathways - providing tailored information to patients, carers and professionals on services to signpost people to the most appropriate place.  Ideally, this could be enhanced with real-time information about capacity.
  • Research - using digital tools to promote involvement in research & clinical trials, to streamline the capture of informed consent, and to capture research data more efficiently and conveniently.
  • Integration - tools that enable the secure, appropriate sharing of information between organisations (e.g. GPs and hospital clinicians) and sectors (e.g. NHS and Social Services) to allow patients to receive seamless care.
  • Data Visualisation - innovative ways of presenting information in a meaningful way to enable more informed decisions by patients and professionals.  This may involve aggregating data from different sources, reporting tools or graphic visualisations such as heat maps.

Ideas (Publish, Detailed Submission)

Innovation 'Elevator Pitch':
Kemuri portable K-Sockets have a 500% return on investment in one year. Use them to accelerate hospital discharge of elderly or frail people into reablement by social services.
Overview of Innovation:



Kemuri K-Sockets are power sockets with multiple sensors that continuously measure:
  • Movement of people in the kitchen;
  • Electrical power for kettles, microwaves or toasters;
  • Room temperature;
  • Power supply.
They send data via the Internet via GSM mobile phone communications.  Kemuri software learns patterns of normal activity and analyses Activities of Daily Living (ADLs) every hour.  As soon as the system identifies too many changes from normal, it automatically alerts people who need to respond to possible risks.  Responders can be families, carers or 24/7 alarm response centres.

The WebApp gives evidence of reablement of the service users.  It gives confidence to responders who have been given informed consent to view the data.  For example:
  • Wandering or unattended falls: Kemuri alerts non-return to kitchen;
  • Nutrition & Hydration: Kemuri alerts risk of dehydration or malnutrition;
  • Engaged the Community: Kemuri apps are free to authorised family, carers or voluntary sector;
  • Active in the home: If people can eat, drink and move around in warm surroundings – then they are performing key ADLs.
Portable K-Sockets are allocated to discharge teams as part of the normal hospital discharge process. Families or other carers have to respond to alerts and determine the action to be taken.  The devices are re-allocated to patients every 6 weeks. Thereafter fixed K-Sockets can be installed in kitchens as wellbeing monitors. 



The cost is less than £500 per year, and the notional saving on bed days is approximately £400 per day.  By using a unit eight times per year, more than £3200 budget is released for more patients.  This represents more than 500% return on investment in one year.  This must be worth a trial in the region.  Additional benefit can come from reduced re-admissions.

Surrey County Council have awarded a grant of £50,000 for measuring the reablement process and subsequent wellbeing monitoring.
Stage of Development:
Evaluation stage - Representative model or prototype system developed and can be effectively evaluated
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Two areas of immediate benefit are the saving of excess bed days for non-medical reasons and the avoidance of re-admission. 
  • Many elderly and frail people cannot be safely discharged from hospital without a period of reablement by family members or professional domiciliary carers.  The NHS typically funds this for a maximum of six weeks – at lower cost than the occupation of a hospital bed.  After assessment and transfer of care to social services, continuous monitoring by K-Sockets permits safe discharges a day or more earlier.  This eases the problems of Bed Managers seeking to release beds for new patients.
  • During reablement, automatic alerts warn of unusual changes of activity.  They could indicate the risk of unattended falls, dehydration, malnutrition of hypothermia; all costly to the NHS.  Appropriate action could avoid the need for re-admission.  
Kemuri is designed for both family carers and 24/7 response services.  Portable K-Sockets require zero installation time and do not require broadband.  Monitoring and machine learning starts within minutes and any people with consent for data sharing can immediately view the data or receive alerts.
 
Longer-term benefits come from wellbeing monitoring after reablement.  Portable K-Sockets can be replaced by fixed K-Sockets.  The data analysis could reveal medical problems, such as UTIs, and preventive action could avoid more costly treatments.    
Initial Review Rating
3.00 (1 ratings)
Benefit to WM population:
Most older people want to return to their own homes as soon as possible after treatment.  Unfortunately, for some independent people, they cannot be discharged because there is no care provision at home.  Perhaps they have no local family or friends.  Consenting to reablement monitoring by K-Sockets could accelerate their discharge and improve health outcomes. 

Families also obtain peace of mind, whether they live locally or at great distances.  At any time of day, people can be alerted to possible problems and respond appropriately.  Most frequently it may only require a reassuring phone call.  On other occasions it could be an unattended fall or medical event that needs clinical action.  Earlier treatment leads to better health outcomes.

It may be possible to reduce the costs of domiciliary care with more-timely and less frequent visits. 
This is an example screen:


A green day shows normal activity.  An amber day shows more changes from normal activity – but may not be cause for alarm.  Red days are alerted during the day and are a call for action.  Viewers can drill down to more detail, and the screen below could indicate the risk of hypothermia.

K-Sockets are invaluable as passive monitors to supplement active telecare devices, such as pendant alarms.  The latter are not worn continuously by 90% of the people who have them and they need reasonable cognition to use them when necessary.  K-Sockets are not stigmatising and do not require any change of lifestyle.

For more information and downloads see http://www.kemurisense.com


 
Current and planned activity: 
Cornwall Council is trialling 20 portable K-Sockets for reablement.  In one case, an alert was sent to a family member before they knew about an unattended fall.
 
Surrey County Council have awarded a grant for TECS Innovation.  The plan is to supply 40 portable K-Sockets for reablement and then supply 100 fixed K-Socket to vulnerable people for six months.  Social Care will perform assessments as part of their normal case management.  An anonymised log of each service user should provide evidence of the bed days saved.  Statistics of readmission or transfer to full-time residential care can be compared to current averages.
 
Many K-Sockets are operational in small trials and some are still operational after years of use in private houses and housing association properties.  They could collect data for several years in long-term trials for clinical trials, such as for drugs for relieving the symptoms of dementia.
What is the intellectual property status of your innovation?:
Kemuri has patents pending; GB1417259.7, effective date of 30 September 2014 and PCT/GB2015/000275, International Filing Date of 30 September 2015. 
 
Kemuri, KemuriSense, K-Sockets and K-Fobs are registered trademarks. 
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regional Scalability:
K-Sockets can be produced in batches of 100 to 1000 from a factory in Woking.  If demand rises, second sourcing could be obtained in the WM region.
 
Web services are cloud-based and rapidly scaled at short notice.  Surrey has the largest scale implementation, which should peak at 140 units.  Scale-up should start by engaging with hospital discharge units and reablement teams.  Services to self-funders and Local Authorities can be scaled up by using the larger telecare service companies who provide other equipment and 24/7 call centres. 
Measures:
Quality
  • Alerting the risk of unattended falls, dehydration, malnutrition and hypothermia;
  • Continuous reliable operation
  • Avoidance of false alerts
  • Identifying unusual activity that may indicate need for medical intervention, eg for UTIs or TIAs.
 
Safety
  • Responding to alerts in time to minimise poor health outcomes;
  • Reduction in re-admissions.
 
Cost
The cost of deploying a portable K-Socket is less than £500 per year.  If this saves an average of one excess bed day per month, then the notional return on investment will more than 500%. 
 
People
The target service users are older people awaiting discharge from hospital who:
  • Need initial support from reablement teams;
  • Live independently and do not normally have daily visitors;
  • Can respond to phone calls;
Responders to alerts may be family members, carers or 24/7 response centres.
 
Ethics
Service users must give informed consent for data sharing with approved people such as practitioners, domiciliary cares and family members.
Adoption target:
West Midlands has a population of 5 million.  Engaging 1000 suitable service users per year is a reasonable target.  100 portable K-Sockets is a minimum viability level.  If successful, then growth to 10,000 service users is practical.   
Read more
Hide details
Leonard Anderson 10/10/2018 - 08:10 Detailed Submission Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
ISL has recently developed a Clinical Trial platform that could be used for collaboration by multiple institutions including NHS/Academia/Pharma/Industry.  Shared protocols, intelligent workflows and secure data management underpin the solution.
Overview of Innovation:
Ensuring your data is accurate, your samples are viable and your results are verifiable are essential when managing clinical trials and carrying out research.

Achiever Medical provides your laboratory with the functionality to manage data quality and integrity, an audit trail to help you assess the quality of your samples and a workflow tool to help map your processes into the solution, including managing the approvals process.

  • Clinical trial functionality to allow easy adoption and customisation for launching and building up clinical trial datasets
  • Manage cohorts, studies, samples, visits and results within a single system that can be shared amongst all collaborating parties
  • One system across multiple institutes, pharma, industry and academia
  • Management reporting cross centre
  • Create and deliver trials quickly with customised data requirements
  • Enforce trial protocols to promote quality and single approach
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Advanced diagnostics, genomics and precision medicine / Clinical trials and evidence / Digital health / Innovation and adoption
Benefit to NHS:
  • Rapid rollout of system to support data capture of clinical trials
  • Modify processes and protocols per clinical trial with minimal recourse to IT
  • Share data regionally/nationally across trials
  • Role based permissions to protect data
  • Single system to administer
  • Adapt processes and protocols for trials quickly
Assess Sample Viability
Ensuring you are carrying out research on viable samples is essential when validating any results.  Achiever provides a comprehensive audit trail against each sample including complete details of storage location history (with a temperature audit),  sample check out history (when, by whom, how long and for what purpose) and sample processing history (with sample collection date/time, processed date/time).  A complete sample family history is also available for managing aliquots with related samples (including parent) accessible with a single click.
 
Maintaining Confidentiality
Confidentiality is not only critical when handling patient information but is also a legal requirement.  Achiever offers flexible, secure data protection options to restrict access to identifiable and sensitive information to authorised users only.  Data encryption routines encrypt data at source whilst data security filters only allow authorised users access to selected information within the system.
 
Managing Studies and Workloads
Define studies within the Achiever system and link team members along with their relevant roles.  Generate activities to create and manage workloads with a graphical calendar available to view team schedules.  Monitor and track equipment and consumables used. Capture analyses and results along with any associated documentation and images.
Initial Review Rating
4.60 (1 ratings)
Benefit to WM population:
  • Make clinical trials available quickly to patients within the WM region
  • Ease of reporting to present efficacy of trial within the region
  • Show proactivity of centres and success in recruiting potential volunteers for trial
Current and planned activity: 
The functionality is being rolled out within a Health Trust in the East of England.  The company now wishes to find a national / regional opportunity that would benefit from a single system to promote trials.
What is the intellectual property status of your innovation?:
Released.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Sandie Shokar 30/08/2018 - 15:55 Publish 2 comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Docly is the leading digital health provider in Sweden, founded by a practicing GP in 2013 to deliver greater efficiency of use of clinician time, better quality of care and better patient experience using algorithm supported online consultations. 

Overview of Innovation:
Docly has been in use since 2013 in Sweden, with over 250k patients consultations to date.  85% of patients prefer it to conventional appointments due to quality of service they receive and the ability to access care how and when they prefer.



Clinicians choose to work in the Docly service (we employ 120 Doctors in Sweden) as they have greater flexibility of time and location and with the security provided by integrated decision support tools.

Efficiency gains are significant with approximate halving of the clinician time taken per consultation.
 
Work Flow

Docly consultations take place securely online: patients fill out a guided questionnaire for the health condition they seeking help for, then submit their case to our Digital Waiting Room.  They can do this via an app or web tool.  These notes become part of the patient’s record, reducing downstream administrative workload.

The questionnaire provides automated triage, refernig the patients to appropriate levels of care. This could be to eg self referral to physiotherapy, or if  the information the patient enters indicates a more serious problem, then the patient is instructed to seek urgent care.
 
The Docly clinician uses their web tool or app to select patients from the Digital Waiting Room according to condition, location, time waiting etc.

Typically a consultation is starts 3-4 minutes after a patient submits their case, with the patient informed of this by a prompt in their app. Most communication between the clinician & patient then takes place asynchronously (ie not real time) in writing.

Doctors can choose to use images, video or phone calls, during the consultation.  They can as would be the case in any normal consultations request tests to progress the consultation to arrive at a diagnosis, decide on any treatment & follow up with the patient, replicating the steps in conventional care but taking the experience online.
 
Quality tools

Decision support tools are integrated into the clinician app are derived from national guidelines and are written and maintained by doctors with significant experience in writing clinical algorithms.

All activity is recorded and reports of clinicians’ work are displayed via dashboards that can also be used as input into appraisals.  The service encourages online peer support from other Docly doctors to pose questions and gather rapid feedback.

Every 20th case a clinician sees, they are prompted to review an anonymous peer’s case to provide a quality feedback mechanism.

Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Digital health / Innovation and adoption
Benefit to NHS:
The demands on primary care services are at an all-time high with the number of consultations occurring in general practice, estimated to have increased by 19 per cent between 2008-09 and 2013-14; against a backdrop of a recruitment crisis in where the UK is estimated to be short of 6k GPs. Non-attendance is estimated to be 5% of appointments further compounding the pressures on primary care.
 
At the same time 75% of the UK population go online for health information & 50% use the internet for self-diagnosis (Department of Health & UK Trade & Investment 2015). 71% of those aged 55-75 have a smartphone (Deloitte 2017)
The traditional models of primary care are less aligned to expectations of patients & are increasingly difficult to access. 
 
Patients

Docly offers high quality, modern & accessible healthcare.
  • Patients are connected through our service to a clinician - usually a GP - within 3-4 minutes (median) without having to leave their home or office, contributing to a better quality of life for patients and improved service over conventional care
  • Net Promoter Score of 45.
  • 85% of patients choose to use Docly for subsequent appointments.
Clinicians

Docly increases capacity for a GP to serve their patients through
  • Faster consultations, typically taking 50% of the clinician time over a conventional appointment.
  • Increased attractiveness for GPs working clinical sessions due to greater flexibility : Doctors can work where and when it suits them, working around other commitments and increasing the available workforce.
  • Triage of patients directly to alternative services without the need to directly engage with the practice
  • Remaining capacity is focussed on those patients who really need to see a doctor in person.
  • High Patient satisfaction
NHS

Docly (known as Min Doktor) is part of the public healthcare system in Sweden, providing online consultations for national & regional public healthcare providers.
  • Cost savings from increased capacity to serve a given population through the efficiencies of increased patient throughput
  • Working alongside existing services in a given geography enhances and augments the total capacity in a given area.
  • Patients stay registered at their own practice
  • Patient satisfaction
  • GP workforce capacity and satisfaction
  • Quality of care: we have reduced antibiotic prescribing driven by guideline derived algorithms by 50% over the last 18M, and similar reductions of referrals to specialist secondary care services also using guideline structured algorithms.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
The West Midlands region is an area of contrasts. It includes densely populated conurbations such as Birmingham, Coventry and Stoke-on-Trent, as well as beautiful areas of remote countryside within the counties of Staffordshire, Worcestershire, Warwickshire, Herefordshire and Shropshire.
 
Sparsity and the increasing scarcity of public transport links are recognised as having a significant impact both on daily living costs of rural households and on access to services.  All of the Sustainability and Transformation Partnerships (STPs) in WMAHSNs rural areas have identified these challenges as priorities in their transformation plans.
 
NHS England is using technology to empower patients and make it easier for clinicians to deliver high quality care and enabling patients to seamlessly navigate the service as part of its digital transformation strategy. The Online Consultation programme is a contribution towards this ambition.
 
Online Consultations are part of the Midlands and East GP Forward View (GPFV) Digital Implementation Strategy.
 
Video consultations can overcome geographical boundaries and provide access to services in remote areas or those with limited numbers of healthcare professionals.  These are however not suitable where low bandwidth mobile networks exist as is the case across much of the west Midlands area, so text based and asynchronous consultations suit this environment well. Currently only 2% of Docly consultations require a video call.
 
Patients using the Docly service do not need to take time away from work to have an appointment, and without the need to video call the doctor, the process is much more appropriate to a work environment.
 
We anticipate that doctors providing the Docly service  would come from within the area contracting with us. If there is insufficient capacity within the local geography, doctors from outside the area can support local patients, and in a reciprocal manner, doctors in the West Midlands could treat patients in other parts of the country.
Current and planned activity: 
The GP Forward View announced £45m to support the uptake of GP online consultation systems. The General Practice Development Programme will help practices lay the foundations for new models of integrated care & play their part in delivering a sustainable & high quality NHS as part of the Sustainability & Transformation Plan process in which general practice has a key role.
 
Docly would like to engage with WM CCGs, Federations and large GP partnerships to explore accessing the above funding to establish the Docly solution across the region.
 
We want to ensure the Docly service is visible to organisations considering online patient triage and consultation tools.
 
In other areas we are working to deploy Docly into practices in Leicester and are designing an evaluation with a large GP federation to quantify the value in an NHS primary care environment.
What is the intellectual property status of your innovation?:
IP Held by MD International (parent company).
Return on Investment (£ Value): 
N/A
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
2
Read more
Hide details
Barnaby Poulton 17/07/2018 - 11:08 Publish 2 comments
5
1
Votes
-99999
Innovation 'Elevator Pitch':
Cera is a multi-award winning, technology-enabled homecare provider. Our technology allows us to respond and deliver tailored care within hours of an enquiry, while empowering our care-workers to deliver the highest standards of care.
 
Overview of Innovation:
Cera is a digital disruptor of the home care space, with in-house and proprietary technology. We have created a platform able to i) create digital care reports whereby during a carer visit, carers log information on their smartphone using our platform, with health and behaviour data on the user, which allows for metrics to be monitored and better care to be delivered – this data is also accessible to family members and healthcare professionals permitting much better connected services; ii) use of artificial intelligence based on the data collected by carers, to predict if users are going to experience health deteriorations such as their blood pressure worsening or the onset of a urine infection, based on subtle signals that carers may have logged – this allows us to escalate a service user’s care should they be at high risk of deterioration, or contact their doctor more proactively, potentially preventing adverse health events or the need to go to hospital; iii) use of an artificial intelligence chatbot – Martha – that provides decision support to carers based on questions they ask. The chatbot aims to transfer some of the knowledge and experience which established carers possess to carers with less experience; by doing this, we aim to make care more consistent.

Cera has provided hundreds of thousands of care hours with a 95% satisfaction rating, and is growing at an average of 25% a month. It has received over £13 million of funding from investors such as Kairos Ventures, Kima Ventures, David Buttress (former CEO of JustEat), Paul Wilmott (leads digital globally for McKinsey), Charles Songhurst (former Global Head of M&A at Microsoft) and Peter Sands (former Chairman of Davos). It has been recognised by the Government's Cabinet Office as a role model for innovative businesses partnering with the public sector, and Sir Nick Clegg recently joined the company. Cera has received a number of awards including the Most Outstanding Digital Health Innovation of the Year, the LaingBuisson Dementia Care Award, the Best London Home Care Company at the Social Care Awards 2018.
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
We are the pioneer of innovative care delivery and have been widely recognised as the UK’s leader in transforming the sector. So far we have delivered hundreds of thousands of care sessions with a 95% satisfaction rating. Crucially, we are often able to start care within 24 hours when requested; this is markedly faster than other companies who take 3-4 weeks, and means that healthy people do not need to stay in hospital waiting for their care to be arranged.
We are developing a Artificial Intelligence platform that utilises data collected by carers to predict if users are going to experience health deteriorations, such as their blood pressure worsening or the onset of a urine infection. This allows us to escalate a user’s care should they be at high risk of deterioration, or contact their doctor more proactively, potentially preventing adverse health events. We are also developing an artificial intelligence chatbot that provides decision support to carers based on questions they ask. The chatbot aims to transfer some of the knowledge and experience which established carers possess to carers with less experience.

At present, clinical doctors are not involved in the active review of our clients’ data. However, there are several members of our clinical care team that review reports from each care visit through our digital care platform. Furthermore, using our digital care platform - where data is stored and viewable - it is possible for us to allow GPs and hospital doctors to access the information relating to their own clients. This would be after authenticating themselves on our platform and be possible through our portal website. We are exploring partnerships with Clinical Commissioning Groups which would allow these data sharing partnerships to be made possible.  ​
 
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
We are offering a better experience for our carers, who are offered flexible working and are empowered using technology, translating to an annual carer retention rate of over 90%. We achieve that by paying them up to 50% more than industry average, and supporting their learning via a combination of in-class and online teaching. Our e-learning platform, Learning Pool, has been very successful in engaging our carers to further their knowledge, improving the overall standards of care we provide.  

The care workers are periodically in touch with family members and are certainly aware of important care-related matters through the family members before they begin care. Care workers and family members always have the option to contact each other immediately through Cera Care at any time. Family members can access the visit reports completed by care workers through our portal as soon as they are completed - we believe this gives them a level of transparency that is simply not possible without a digitised solution. We have a comprehensive and clear consent process which all clients must sign before we deliver any care. The scope of this consent covers data capture by care workers, data storage on our platform and processing such as this for the purpose of improving patient care.
 
Our machine learning algorithm is also a work in progress - currently in prototype form. It uses data from the client’s care plan (past medical history, medication, important disabilities, care schedule) and visit reports captured by visiting care workers (mood, nutrition, hydration, activity level, sleep, bowel movements) to attempt to predict when clients are at high risk of experiencing a deterioration in their health. Currently it has an AUC ROC of 0.72. As we collect more data, we will continue to improve its performance. Since we have not operationalised this prototype, we do not require ethics approval and it is not considered a medical device because it does not offer medical diagnostic capability nor does it actively conduct treatment. If we decided to use it to inform our care workers’ practices - we can register it as a Class I device.
Current and planned activity: 
In 2018 we have delivered NHS CCG funded care with the following CCGs: Lambeth, Tower Hamlets, Haringey, Enfield, and previously had partnered with CCGs including Brent, Harrow and Hillingdon, and East London Foundation Trust, in addition to marketing in NHS hospitals including: Central Middlesex, West Middlesex, Northwick Park, Royal Marsden, Whittington and Barnet & Chase Farm and a Marketing Agreement with BMI hospitals across London. NHS 111 is exploring a collaboration with Cera. One potential outcome of this would be to permit the integration of data records from Cera into the 111 service
What is the intellectual property status of your innovation?:
We own IP for our Digital Care Platform and algorithm
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
3 years +
Ease of scalability: 
3
Read more
Hide details
Sara Sliwinska 09/07/2018 - 15:00 Publish 2 comments
5
1
Votes
-99999
Innovation 'Elevator Pitch':
Clinical decision making improved via proactive digital remote monitoring. Together driving cost efficiencies, improving patient outcomes & avoiding hospital admissions. (CE Class 1a: data server sits within HSNC:  proven ¯ 67% admissions: scalable)
Overview of Innovation:
CliniTouch Vie is a digital health solution that reduces unnecessary hospital admissions.
 
CliniTouch Vie is a locked-down tablet with integrated 3G for intensive monitoring, education & empowerment with integrated direct messaging & video support.  Dynamic care plans & evidence-based algorithms enable automatic triage for healthcare teams.  Fast & simple to implement for the most at-risk patients. 
 
Launched in 2016, system is CE marked & MHRA approved. An evidence based digital health platform that clinically supports patients to better manage their condition. It has the flexibility to be adapted for data analytics & clinical decision-making support in chronic disease management (eg COPD, heart failure & diabetes), frailty & assisted discharge programmes for ambulant & non-ambulant patients
 
Clinical & economic evidence has been generated from trials with 300 respiratory patients [Ghosh et al, 2016, https://doi.org/10.12968/bjhc.2016.22.3.123]. Our evidence based digital solution increases patient access to care & promotes greater clinician-patient collaboration for the 15million people with LTCs. It drives timely, proactive intervention, minimising need for more acute costly care enabling sustainable long-term outcomes success
 
USPs:
Evidence based: Study published in the British Journal of HC Management showed 67% reduction in unscheduled COPD admissions & saving of £2,278 per patient pa. (NB: programme continues to deliver same level of savings)
 
Patient-centred: Personalisation of goals, metrics & parameters makes system truly patient centred providing real-time remote monitoring closer to home to improve patient experience & outcomes whilst generating savings
 
Secure & integrated: Data server sits within HSNC enabling it to push-pull data securely between healthcare provider & service users. Includes bespoke integrated secure video-conferencing platform with end-to-end encryption, allowing remote monitoring of medical conditions, improving quality of life & avoiding unnecessary admissions
 
Flexible Modular Architecture: Enables clinically validated question sets re: symptoms, to be easily tailored to specific therapy areas for qualitative data collection
 
Tiered Service: no upfront costs to NHS on PAYG basis:
- Digital platform integrated into existing healthcare pathways
- Light touch triage service informing local health teams of urgent priority patients for interventions
- Fully-Managed digital platform and nurse-led service providing triage & interventions
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
CliniTouch Vie has proven benefits and can be scaled up easily across the wider regions:
  • improved patient outcomes:
  • 67% reduction in COPD emergency admissions;
  • 13% improvement in CAT score
  • 97% of patients using CliniTouch Vie will further reduce distress and discomfort from conditions exacerbations
These were supported by:
  • improved access to healthcare: 24/7 access to healthcare, average 110 interventions per patient per annum (500% increase)
  • targeted and personalised health interventions: 7,250 personalised clinical interventions (data from 66 patients over 12 months)
  • data analytics: real-time clinical dashboards for clinical teams to prioritise patient needs; prioritised only 38% of patient clinical recordings required intervention within a 24-hour period
 

 
Patients are educated and supported to interpret the data to gain an improved understanding of their health status.CliniTouch Vie:
  1. Educates patients: supporting people to make health life choices through improving the understanding of their disease and self-management skills
  2. Enhances care for patients with chronic conditions: informing and engaging patients as part of NHS prevention agenda and creating a patient-provider collaboration
  3. Provides data analytics: making more targeted and personalised health interventions, by using disease specific algorithms to differentiate when one patient’s history or recent environmental exposures indicates a higher likelihood of flare up than another
  4. Improves patient safety: providing real time clinical and well-being data to identify early warning signs of health deterioration, medication adherence and self-management education
  5. Reduces hospital activity: providing real time management of high risk patients to prevent admissions
  6. Supports early discharge: providing hospital level diagnostics and monitoring in the home, enabling early discharge and can be used for remote clinical support post-surgery or in care-home settings
  7. Delivers workload efficiencies: supporting better patient self-management, reducing need for direct interventions and enabling staff to focus on priority patient care
  8. Offers locality wide cost savings: reduced demand leads to reduced NHS activity
 
Initial Review Rating
5.00 (2 ratings)
Benefit to WM population:
The West Midlands priorities that CliniTouch Vie can address are:
  • P2: Long Term Conditions: whole system, person centred approach
  • P4: Wellness, healthy aging and prevention of illness
  • P8: Digital Health
 
Our vision is for CliniTouch Vie to contribute towards and support the West Midlands wider vision to develop a worldwide reputation for delivering healthcare through digital technologies, proven to deliver sustainable improved outcomes and create wealth.  We have already demonstrated that it can deliver on all fronts with high risk COPD patients and is being adopted for Heart Failure, Diabetes, Cancer and Frailty pathways.  With an ageing population, often with co-morbidities, it can be used to support a more patient-centric approach to health care services in the region.
 
CliniTouch Vie supports health and wealth benefits as is a flexible, real-time remote monitoring solution, facilitating earlier discharge, prevent readmissions, reduce risk of future exacerbations and improve self-management through our inbuilt education resources.  CliniTouch Vie delivers a proactive approach to tackling symptoms, preventing exacerbations and slowing health deterioration, resulting in reduced NHS costs.  The system has an extensive data collection of medical, lifestyle, biometric and daily activity.
 
Targeting patients who are at risk or have multiple hospital admissions could significantly reduce the NHS costs to the region as well as freeing up clinic and nurse time to manage a wider caseload more efficiently. With a more collaborative, integrated, patient centred approach, utilising proven remote digital health, the West Midlands could see a potential reduction in admissions by 60%+.
 
CliniTouch Vie is a locked-down tablet, with integrated 3G for intensive monitoring, education and empowerment with integrated direct messaging and video support.  Our dynamic care plans and evidence-based algorithms enable automatic triage for healthcare teams. 
 
The tablet comes in an easy to carry case with the peripherals and can be handed to the patient at home, in clinic or upon discharge and is linked directly to the clinician web-based management portal.  Data within CliniTouch Vie tablet is stored securely within the cloud and hosted on the N3.  This makes CliniTouch Vie easy to scale due to its low technology and estates requirement, whilst delivering a high quality clinical service.
Current and planned activity: 
Current:
Spirit Digital is part of Spirit Health Group and can provide one of the most comprehensive range of solutions to support patients of all ages, IT capabilities & levels of disease severity across a wide range of conditions e.g. respiratory, cardiovascular, diabetes, cancer, frailty.
 
Spirit is establishing research collaborations with academic institutions around evidence generation for AI and machine learning. This includes collaboration on a bid to the European Space Agency to further develop the technology using satellite data.

Planned:
Spirit Digital seeks WMAHSN support ta assist with introductions and marketing of CliniTouch Vie to local CCGs. 
 
Our planned NHS engagement activity programme for the next 12 months will be through a variety of channels:
  • Direct engagement with CCGs and community Trusts
  • Application to Digital Accelerator programme
  • Case study development & sharing
  • Presentations at national conferences
  • Creating user (clinicians & patients) video footage to share with CCGs
What is the intellectual property status of your innovation?:
We hold the IP for the technology and digital health algorithms.  We collaborate with Midlands based businesses, healthcare providers and universities and retain all IP for products and services.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
2
Read more
Hide details
Emma-Jane Roberts 21/06/2018 - 11:25 Publish 1 comment
5
1
Votes
-99999
Innovation 'Elevator Pitch':
QxMD is a company dedicated to creating point-of-care applications created by for healthcare professionals, with a global community of 1.9 million clinicians, medical students, scientists and researchers and are free to download and use at any time. 
Overview of Innovation:
Healthcare professionals need to stay up to date on the latest medical research and topic reviews to provide optimal care. Unfortunately, the process of content discovery is broken with research artificially compartmentalised by publishers and hidden behind countless institutional paywalls.

At QxMD, we believe that knowledge translation– the process by which new knowledge is incorporated into clinical practice – is an important and unsolved challenge for our health care system. Read uses smart algorithms to ensure that each and every user has a dedicated newsfeed of research that applies to their practice. 
With Read, Institutional Edition, organisations can seamlessly integrate their existing journal subscriptions and existing proxy service to provide a platform for their clinical staff to access content which matters to their individual practices. It is built with features designed to improve patient care and reduce costs. 

The Promoted Research feature is used by institutions who want to disseminate research that impacts areas of care the most within their organisation. For example, a Hospital with high rates of Sepsis can use this tool to promote guidelines that reduce Sepsis cases with higher guarantees their clinical staff will discover the research and apply it to the next patient. 

Librarians and Knowledge Managers can take advantage of smart analytics to understand which journal subscriptions are performing the best and worst and also which journals are most popular, which they don't subscribe to.

NHS Trusts are already adopting QxMD, with over 100,000 users in the UK alone. 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety
Benefit to NHS:
  • Better educatad and up-to-date staff, specific to their practice
  • Cost saving on journal subscription costs
  • Improved patient care
  • Challenges identified and tackled via the Promoted Research feature
  • Easy to discover and access research from any smart device
  • Links with OpenAthens for instant access to subscribed content. 
Initial Review Rating
2.60 (1 ratings)
Benefit to WM population:
  • Better educated healthcare professionals who can identify the latest research and apply it to patient care
  • Less chances of mis/under diagnosis, readmission or even death
  • Improved quality of care
Current and planned activity: 
  • Existing NHS Trust clients, including the largest Mental Health Trust in the UK
  • Continue to grow our userbase, which is already at 100,000 UK users, with the support of Trusts and other stakeholders. 
What is the intellectual property status of your innovation?:
  • We have designed and developed the platform entirely in-house. No white-labelling. A completely unique tool built by Healthcare Professionals for Healthcare Professionals. 
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Read more
Hide details
Jimmy Connoley 19/06/2018 - 11:56 Publish 1 comment
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Currently Continuing Healthcare Assessments are often paper and phone based, involving multi-disciplinary teams across different organisational silos. Our intuitive Continuing Healthcare tool transforms the CHC & DST process for safe and better care.
Overview of Innovation:
The current process of Continuing Healthcare Assessments is often paper and phone-based and involves the co-ordination of multi-disciplinary teams across different organisational silos.
 
A lack of transparency in the assessment process can lead to unnecessary delays. One team’s uncompleted task can halt the entire process; whether it be because of admin delays on missing paperwork, incomplete assessment information or delays in communication. 
 
Delays, lack of progress and poor visibility cause considerable distress to patients and their families as they wait for funding assessment, decision and care provision.
 
NHS England has introduced new quarterly CHC reporting in order for CCGs to monitor performance as many fail to achieve the National Standard turnaround of more than 80% of eligibility decisions within 28 days. On the reward side, NHS England has made the annual achievement of the National Standards for CHC subject to a valuable Quality Premium.
 
Continuing Healthcare assessment transformation starts right here.
 
CHC2DST eliminates paper from the Continuing Healthcare assessment process.  It provides a single point of entry for assessments into your organisation. From Day 1 you begin to control the CHC workload and workflow, rather than the other way around. Through the elimination of paper and the automation of communications between process stakeholders, CHC2DST provides CHC leaders with the transparency they require to improve their service levels.
 
CHC2DST increases the productivity of stakeholders within the CHC assessment process, reducing time spent on low-value admin tasks and allowing them to focus their time, knowledge and skills to drive improvements and generate value into other Continuing Healthcare areas. 
 
With CHC2DST user organisations are able to configure the solution to the assessments, permissions and workflows that suit their local situation.
 

 
Benefits of CHC2DST
  • Improve the assessment services to patients and carers and staff
  • Improve communication across stakeholders
  • Improve decision making speed and accuracy
  • Reduce Delayed Transfers of Care numbers
  • Improve work allocation and follow-up scheduling
  • Improve accuracy and retrieval of completed CHC Checklist and DST
  • Reduce legal appeals through better record keeping
  • Reduce processing costs by eliminating inefficiencies
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Digital health / Innovation and adoption
Benefit to NHS:
NHS continuing healthcare (CHC) is a package of care provided outside of the hospital that is arranged and funded solely by the NHS for individuals aged 18 years and older who have significant ongoing healthcare needs. When someone is assessed as being eligible for CHC, the NHS is responsible for funding the full package of health and social care.
 
Funding for ongoing healthcare is a complex and highly sensitive area, which can affect some of the most vulnerable people in society and those that care for them.
 
The Continuing Healthcare Checklist and the Decision Support Toolkit assessment process is inundated with paper-based forms filled out manually by health and social care professionals. As a result, professionals at the centre of the CHC process struggle to synthesise the information from the reams of paper they receive adding to unnecessary discharge delay.
 
CHC2DST is an end to end digital administration and assessment solution for CHC. It digitises and automates data collection and processing of CHC & DST. We have been able to demonstrate the potential for huge savings in the CHC assessment procedure. Savings are generated by both a reduction in administrative burden and a reduction in the delayed transfer of care. 
 
Implementation of our CHC2DST solution will provide efficiency benefits & savings across the health and care system. 
  • Cost saving for a CCG on average is around £300,000 for administration time, faxing, paper copying and postage costs. 
  • Saving to a Local Authority by improving transparency and speed of assessments will enable the improved efficiency of staff time and provide improved visibility for social workers of the cases being assessed.
  • The government and NHS target is to get through the process in 28 days and over 50% of the cases do not meet this target. Implementing our CHC solution will provide improved communication/transparency to family members and reduce the time taken for the assessment process. Families should get answers quicker and the Health system will come closer to achieving their 28-day target.
To realise the benefits the CHC2DST can bring to your organisation, download our free full economic assessment, simply visit our website, enter your details and then submit – click here.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
NHS England has put CCGs’ execution of the Continuing Healthcare process under the spotlight.  NHS Leaders want to drive up productivity by eliminating inefficiencies in the Continuing Healthcare. On a macro level, NHS England is setting out to save £855 million across CHC delivery by 2020/21. Improving the speed accuracy and consistency of access to CHC will be important in achieving this goal.  
 
From an operational perspective today, they believe challenges in CHC assessments are contributing to unnecessary Delayed Transfers of Care in the acute system, with too many full assessments being conducted in an acute setting. Additionally, many CCGs are failing to achieve the National Standard for the turnaround of more than 80% of eligibility decisions within 28 days.   
 
Continuing Healthcare assessment transformation starts with CHC2DST.
 
CHC2DST is easy to use and intuitive, eliminating paper from the Continuing Healthcare assessment process. Through the elimination of paper and the automation of communications between process stakeholders, CHC2DST increases the productivity of stakeholders within the CHC assessment process, reducing time spent on low-value admin tasks and allowing them to focus their time, knowledge and skills to drive improvements and transform the CHC & DST process for safe and better care.



At least 16 days can be taken out of the of the current process using CHC2DST’s digital solution.
 
The CHC business case is an example of the efficiency benefits and potential cost savings that you could realise by implementing the CHC2DST into your hospital and CCG. To discover more and download our free economic assessment, simply visit our website, enter your details and then submit – click here.

Current and planned activity: 
CHC is under the spotlight from many areas including NHS England, the Public Accounts Committee, National Audit office and has been identified as a major workstream for NHSE with a strategic Improvement Programme to 2019 set up.
 
The Quality Premium incentive for CCGs also features CHC heavily (17% of total award). Many policy levers are now in place to attempt to deliver widescale transformation on the service.
 
We would like WMAHSN’s support to assist with engagement of our target audience CCG’s to help to scale our innovation to further the region’s improvement in quality and performance for CHC.
 
What is the intellectual property status of your innovation?:
IP is held by IEG4 for the code used in developing the software application. NHS IG governance toolkit 14 approved, deployed on the Microsoft Azure could service which achieves the highest accreditation for security.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
2
Read more
Hide details
Charles MacKinnon 21/05/2018 - 13:13 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Using pathways and simulations to generate a synthetic population, informed by known population and health statistics, to act as a safe and effective testing environment for digital health solutions.
Overview of Innovation:
We are using pathways and simulations to generate a synthetic population, informed by known population and health statistics. This is intended to act as a testing environment, providing evidence for the decision-making, implementation and evaluation of all policies that impact health, whilst eliminating the risk of using real patient data.

The process involves conducting a document analysis on relevant documents, clinical guidelines and standards to set the scope of the project and identify the important information items that need to included in the model. Existing pathways can be used or, based on evidence from the document analysis, new pathways created to include care, disease progression or system management pathways. A synthethic population is then generated using Census data for the specific locality, to reflect the same demographic distributions of the real population. This population are then run through the pathways and at each clinical interaction on the pathway, a digital exhaust can be produced that reflects those seen in real systems. The pathway execution stage also produces an event log detailing the steps and relevant information (e.g. costs and waiting times) for each individual in the population. These outputs can then be analysed using data visualisation tools to provide an interactive dashboard that visually tracks, analyzes and displays they key performance indicators (KPI), metrics or key data points needed for the project.

This approach can be used to support service design, business case development, clinical engagement, user prototyping, supplier testing, training, demonstration, software product testing and resources for hackathon events.

This is a scalable and reusable approach that will be of particular value following the implementation of the GPDR in May 2018 when anyone interested in data-driven improvements for health will need synthetic data.
Stage of Development:
Evaluation stage - Representative model or prototype system developed and can be effectively evaluated
WMAHSN priorities and themes addressed: 
Digital health / Innovation and adoption
Benefit to NHS:
This approach has many valuable use cases for the NHS, including:
  1. Service design 
    • Building pathways in a standard format and using a realistic synthethic population, the workload, outcomes and risk factors affecting the service can be illustrated and reviewed
  2. Business case development 
    • Running the model twice, once with and once without a planned service change, allows the delivery, benefits and risks of a new service to be monitored
  3. Clinical engagement 
    • Engaging pathway diagrams and credible synthetic health records bring a project and the use case to life, helping to engage clinicians throughout a project, enabling issues and misunderstandings to be identified and resolved early
  4. User prototyping
    • Providing realistic data for early prototype screens and documents to verify user needs and set expectations will facilitate an easier, quicker and cheaper process of iteratively building, testing and adapting ideas
  5. Supplier testing
    • Providing an extensive set of synthetic data is able to simulate a wide range of scenarios for system testing, without using real patient data that has privacy restrictions
  6. Training 
    • Generating live synthetic data that is close to the real population in terms of age/sex/household composition/clinical history can be used to train clinicians on how to use the current systems, without using real patient data
  7. Demonstration
    • Using a population and clinical pathways that are relevant to the specific customer is more engaging and better for demonstrating the value of the product for the clients use case
  8. Software product testing
    • Synthetic data, that replicates real patient data but is free from privacy restrictions, can be generated to provide software developers with a rich testing framework, allowing them to build, test and improve their products before deployment
  9. Hackathon resources
    • Providing a synthetic population and library of pathways prior to an event will help to set the scope of the hackathon
    • A toolkit to generate relevant test data can then also support projects that emerge during the hackthon, improving the productivity and value of these events
Initial Review Rating
3.00 (1 ratings)
Benefit to WM population:
This approach will improve the safety and efficiency of patient care in the health service in the West Midlands, support interoperability and innovation and ensure patient data is protected from privacy and confidentiality issues. This will have a huge range of benefits for the West Midlands population, from better care to more control over the use of their data.
Current and planned activity: 
We currently have two proof-of-concepts projects;
  1. Supporting a business case for a Fracture Liaison Service 
  2. Generating the FHIR resources and profiles for a synthethic population of asthma patients
We are looking for research partners or Trusts interested in putting together a joint-bid for some EU funding to explore and assess the technical feasibility and commercial potential of this approach. We would also be interested in working on individual use cases with digital leads or with standards development organisations to develop this as a system-wide approach.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regulatory Approvals:
Please describe any current regulatory approvals you have achieved and how they were met/ in progress/planned.
Commercial information:
Please describe how the product/service is being developed commercially, whether in development, trials, pilot or full commercial delivery. Include the results you have from any market/demand surveys and forecasts . Please include any research you have on the broader commercial opportunity for the innovation both within the health sector nationally and internationally.
Investment activity:
Please describe what stage of investment you have reached and whether you are seeking additional rounds of investment. Please include cash investment as well as investment of soft assets such as access to specialist equipment, knowledge, trial base etc. and indicate the types/sources of your investment such as grants etc.
Regional Scalability:
Please describe how the innovation could be scaled across the WM region. Have you implemented at scale in any other regions?
Measures:
What outcomes are you hoping to achieve and what are the measures that you will use to gauge the success of the innovation and how will these assessments be made? Please ensure that you have quality, safety, cost and people measures.
Adoption target:
What are the targets for adoption across the WM and what are the minimum viability levels?
Investment sought:
What investment are you looking for in order to support wider adoption of this innovation and what have you managed to secure to date? Please provide a breakdown of these costs if possible.
Read more
Hide details
Allie Short 19/03/2018 - 15:29 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Sensium accurately & reliably monitors & transmits patients’ vital signs every 2 minutes & notifies of deterioration between Observation rounds. Easy to use, SensiumVitals provides tangible benefits for patients, clinicians & for the hospital.

Overview of Innovation:
In general care areas of a hospital vital signs are typically taken during routine observation rounds once every 4-8 hours. If a patient deteriorates between these observation rounds the warning signs can go undetected for hours, potentially leading to serious & costly consequences.
 
Sensium is a discreet, wearable, wireless system for monitoring vital signs of patients outside of high acuity areas. A light comfortable sensor worn on the patient’s chest accurately & reliably monitors & reports vital signs providing data every 2 minutes. By notifying clinicians of changes in patients’ vital signs Sensium brings the nurse to the deteriorating patient. This includes patients on general wards, post-operative med/surg. wards & patients waiting before & after treatment in A&E departments.
 
Sensium Patch provides accurate & continuous monitoring of the 3 key leading indicators of patient deterioration: heart rate (HR), respiration rate (RR) & axillary temperature (T). Sensium wirelessly communicates this physiological data via safe & secure low power wireless communication to the Sensium bridges placed through the ward area.
 
The bridges are connected into the hospital IT system, & software installed on the hospital network allows patient data to be seamlessly conveyed. Crucially, notifications can be configured to work with hospital pager systems/mobile notification devices, giving the clinical team data when they need it, where they need it. To save time & ensure accuracy Sensium can be easily integrated with the hospital admission, discharge, transfer systems & electronic medical records.
 
Sensium allows patients to ambulate freely, untethered to static & expensive equipment whilst still having the reassurance of continuous monitoring.
 
The 3 most serious, costly & avoidable care incidents in unmonitored patients are: Sepsis, Cardiac arrest, Respiratory depression. 
  • In Britain more than 100k people suffer from severe sepsis each year. 37k of them will die from the disease. Each case of severe sepsis costs the NHS £20k meaning treatment costs £2bn a year.
  • There are approx 25,428 in-hospital cardiac arrests in the UK per year. More than 80% of hospitalised patients who suffer a cardiac arrest do not recover.
  • 1 in 100 patients treated with opioids for moderate to severe post-operative pain will experience events related to respiratory depression. 17 In the UK there are approx 7m operations performed each year resulting in a potential 70k cases of respiratory depression.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Digital health / Innovation and adoption
Benefit to NHS:
75% of all adverse events & preventable deaths occur outside the ICU in unmonitored beds.

All hospitalised patients are at risk of deterioration but most catastrophic incidents are preceded by periods of change & abnormality in patient’s vital signs. If these changes in vital signs are detected & reacted to in a timely fashion then a significant proportion of costly patient deterioration can be avoided.
 
Currently approx. 10% of patients are harmed during their hospital stay & this represents a cost to the NHS of over £2.5b just to cover the additional length of stay for these patients. Improved monitoring regimes & early detection of deterioration is key to reducing this significant burden.
 
Sensium notifies the clinical team of patient deterioration allowing intervention before the condition worsens, thereby improving patient outcomes, shortening hospital stays & lowering treatment costs. It enables nurses to prioritise patient care where it is needed most.
 
Sensium is focussed exclusively on general care clinicians whose patients currently do not have the safety & security of continuous vital sign monitoring.
 
The system is configurable to display up to 24 hours of vital signs trend data. Highly flexible, Sensium allows clinicians to configure alert levels for each vital sign as appropriate to their clinical environment.
 
For the Clinician:
  • Real-time, early detection & notification of patient deterioration
  • Ability to access information at the nurse station or via other web-enabled devices
  • Integrates with existing workflow without customisation
For the Hospital:
  • Improves patient recovery & reduced length of stay
  • Avoids high cost treatments through early detection
  • Quick & easy to integrate into existing systems
For the Patient:
  • Non-intrusive, lightweight & comfortable to wear
  • Provides reassurance of continuous monitoring
  • Non-restrictive, allowing freedom of movement
Patient deterioration is a significant & growing problem but there is a mounting body of published evidence that supports early identification of the changes in physiology as the most critical factor in avoiding these dangerous & costly episodes. Studies suggest that the greatest area for improvement is not treating the deteriorated patient but more importantly early identification of the deteriorating patient. Delayed recognition of the signs of patient decline is the strongest predictor of patient mortality. To view the evidence, along with our case studies, click here.


Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
With ageing populations driving healthcare demand & heightened expectations of quality of life during & post medical treatment the NHS is under increasing pressure to achieve more with less.
 
Cost effective patient monitoring regimes will become increasingly important to:
  • Improve patient outcomes
  • Reduce care costs associated with expensive & largely avoidable patient deterioration episodes
  • Drive clinical effectiveness through data & evidence-based decision making
The increasing incidence of sepsis is likely to be due to people living longer & more medical/surgical interventions being performed. People with co-morbidities are more likely to survive their illness & for longer than before, which leads to much of the hospital-acquired sepsis that now occurs.
 
Data for finished discharge episodes with a primary or secondary diagnosis of sepsis for patients in England 2010-15 is below.



On average each UK Acute Trust will spend £13m on sepsis treatment & management annually.

The chart below is from Key statistics from the National Cardiac Arrest Audit 2015/16 report, based on data for in-hospital cardiac arrests in NHS acute hospitals.
 

Cardiac arrests are usually preceded by measurable changes in vital signs, by monitoring & reacting to these changes a significant proportion of in-hospital cardiac arrest deaths can be predicted & ultimately prevented.
 
Postoperative opioid-induced respiratory depression is a significant cause of death & brain damage. The Anaesthesia Closed Claims Project database of 9,799 claims was reviewed by 3 authors reviewing 357 claims that occurred 1990/2009 for the likelihood of RD using literature-based criteria. 97% were judged as preventable with better monitoring & response.



Deterioration can happen between observation rounds. If a patient deteriorates between these rounds the warning signs can go undetected for hours potentially leading to serious & costly consequences.
 
Working as your early warning system, Sensium provides affordable, real-time monitoring for patients:
  • Notifies of deterioration: delivered direct to relevant caregiver
  • Tracks HR, RR & axillary temperature: the 3 vital signs widely used in clinical practice as leading indicators of patient decline
  • Eliminates cross infection risk: through single use Sensium Patches
  • Allows free movement: for patients throughout the connected area
  • Offers seamless integration: server software easily integrates with ADT, AD, EMR etc
  • Comfortable for patients: light-weight, unobtrusive patch
Current and planned activity: 
We would like to engage with WMAHSN’s Patient Safety Collaborative Network through the Meridian online health innovation exchange to share our innovative solution to help deliver on improving patient safety across the West Midlands region. Specifically, Sensium would like to give hospitals in the West Midlands region the opportunity to realise the clinical and economic benefits associated with closer monitoring of patients’ vital signs.
 
Patients die because signs of deterioration are missed. There is a huge unfulfilled need for better monitoring of vital signs to identify high-risk patients who are on general hospital wards. Patient deterioration is often overlooked or not detected at all. One of the reasons is the intensity in nursing and frequency of vital signs monitoring which decreases from the Intensive Care via ward towards home. Early detection of physiological instability is crucial to prevent death and disability.



Further details: nightingale business case proposition.
 
What is the intellectual property status of your innovation?:
Aspects of the core technology are patented (14 separate patent families) to ensure freedom to operate.
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Rory Heaslip 14/02/2018 - 08:37 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
‘Uber’ for the NHS. Hospitals crate shifts & push them to only the relevant candidates. Those interested apply with a single click. Hospital admins award the shift to the best candidate. When the job is done both sides leave feedback.
Overview of Innovation:
Megalist is a staff management platform.
The single biggest threat to the NHS is the staffing crisis which affects every other aspect of the NHS.
The is no reason why a large organisations like an NHS Trust with thousands of employees can not share employees to load balance their staffing needs. For example ITU nurses covering A&E.
The only reason for not doing that is that the NHS does not have the infrastructure to do such a thing - to load balance staff between departments, sites, hospitals or even Trusts.
It’s time to rethink the old model.
An NHS employee is an NHS employee and there is no reason that if the have the necessary skills that they wouldn’t be able to cover shifts in a different position in the NHS.
The agencies have been providing the NHS with this integrated infrastructure and charging a very hefty price for it and in all fairness delivering a mediocre service at best.
Megalist provides an innovative solution of a distributed staff management system.
Instead of one secretary calling and emailing everyone and then emailing or calling the agency who emails and calls the staff on their books and they email and call back to the agency who emails and calls the secretary who finds the consultant or the nurse in charge and they vet the agency worker and then they call and email the agency who calls and emails the doctor or nurse who might have taken another job already.
Megalist is a distributed staff management platform - meaning that many people have admin rights: senior doctors, senior nurses, site managers, secretaries, rota coordinators, departmental manages, night mangers and so on. They can all create a shift and push it directly to the relevant people who get the offer directly on their phone and who can respond with a single click.
Hundreds or even thousands of people can be notified in seconds and relevant candidates can be found in minutes not hours or days.
The admin awarding the shift has a lot more information at hand - feedback from previous shifts, how many shifts the candidate worked in the past and where, full electronic resume, photo, relevant documents in our document exchange and much more.
The main benefits are admin staff spend significantly less time finding staff and can do other tasks. Agency spending is cut drastically and having a fully staffed department means increased patient safety, increased patient satisfaction, increased employee satisfaction and thus higher productivity.
 
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Education, training and future workforce / Innovation and adoption / Patient and medicines safety
Benefit to NHS:
The main benefits are admin staff spend significantly less time finding staff and can do other tasks. Agency spending is cut drastically and having a fully staffed department means increased patient safety, increased patient satisfaction, increased employee satisfaction and thus higher productivity.  
Initial Review Rating
4.20 (2 ratings)
Benefit to WM population:
Same as above but for the local polulation. 
Current and planned activity: 
We have ran a successful pilot in St. Thomas' A&E - for doctors only - SHOs and Registrars and in the 34 months which we were developing the platform we covered from them 1142 shifts. 

If you extrapolate that: 

Agency average margin £10 / hour / shift
Average shift 10 hours 

£3,4k / month / deparment / role (eg. doctors)
£40k / year / deparment / role (eg. doctors)

If an average department has 3 roles - doctors, nurses and nursing assistants, but most have more
And an average hospital has 10 departments but most have more 

Than the savings easily exceed £1M annualy.


Please see a short 60 second animation that explains the concept in more detail:

https://vimeo.com/232833427

And some testimonials from real end users.

https://vimeo.com/238748695/f23f1c6ce3
https://vimeo.com/239816983/781e206e76
https://vimeo.com/239817899/ed97fc21fe
https://vimeo.com/239818102/dfdad9f6ff

We are looking for help to get into and NHS Trust. 
What is the intellectual property status of your innovation?:
It is fully owned by Megalist Limited
Return on Investment (£ Value): 
medium
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Regional Scalability:
Appart from building our system we have build an adjacent system that stress tests our main platform and we have tested it to 5,000,000 users without any problems. 

We are ready to scale regionally and nationally. 
Measures:
We have proven that we can cover 40-65% of shifts that are posted trough Megalist. We would like to scale this and provide safer staffing levels across other NHS Trusts. 
Adoption target:
Ideally we would like to get the first paying NHS Trust on board - provide value for them and than with that scale regionally and nationally across the entire NHS. 
Read more
Hide details
Anonymous 09/11/2017 - 20:50 Detailed Submission Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Currently, a GP refers Obstructive Sleep Apnoea patients to an NHS Specialised Sleep Centre. Averaging 24 wks & 3-5 hospital visits before the Patient starts treatment.
Now, a GP with SOMNOtouch can receive results in 48-72Hours (3days vs. 6Mths)
Overview of Innovation:
Currently
The vast majority of patients with Obstructive Sleep Apnoea (OSA) are referred by their GP to a Specialised Sleep Centre at an NHS Hospital with a Average waiting time 12 Weeks


Patients are initially seen by a Consultant or a Sleep Physiologist who would prescribe a Diagnostic Study to be performed either in hospital or at the patient’s home. Average waiting time 12 Weeks
The patient returns to have the sleep study done or to collect the monitor and then returns the device the next day. After a further waiting time of upto 6 Weeks the patient visits the hospital again to obtain the results of the sleep study and if Positive, to discuss treatment.
A letter is sent to the GP informing them of the results and if agreed, a prescription is issued by the GP for the recommended therapy this may also take an average of 6 Weeks to arrive.
 This is prior to any treatment being administered such as a CPAP where if used they attend annually to check on compliance and progress.
 
This 6 month process is dramatically reduced by the S-Med Service to just a few days before an intervention can be delivered.


Now
The GP fits SOMNOtouch, a Combined OSA/Hypertension Monitoring Device to the patient, after 24 hours they return to the GP practice where the device is removed and the GP uploads the data from the device to a secure NHS Digital Cloud Server.
SOMNOtouch NIBP - Five devices in One
Video link: http://www.s-med.co.uk/Products#nav-product-86
 
S-Med Ltd’s Qualified and Registered Physiologists interprets the study and provides a recommendation for further treatment or investigation within 24 to 48 hours to the GP surgery. (All analysis and interpretations are supervised by a senior Consultant).
 
The report is sent to the GP who would then provide a prescription for the relevant therapy to be provided.
 
Thus within 48 to 72 hours a patient can be treated or directed for additional investigations or treatment before their condition deteriorates.

 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Advanced diagnostics, genomics and precision medicine / Wellness and prevention of illness / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Faster response times and time to providing treatment from an average time from referral to treatment of 6 months (24 weeks) down to 4 to 5 days (1 week). With the added benefit if there are more critical underlying conditions then these may be picked up and dealt with quickly
 
Reduction in costs of patients being referred to NHS sleep centres thus less calls and pressure on such specialist clinics e.g.:
 
Reimbursement Tariffs for OSA and Hypertension
Current reimbursement guidelines from the Department of Health are:
  • For Ambulatory Sleep Diagnostic Study: £391.00
  • For 24-Hour NIBP Study: £268.00 (UCL NHS Foundation Trust, there is no NHS tariff)
  • For 24-Hour ECG Study: Recording - £268.00 plus Analysis £215.00 (UCL NHS Foundation Trust, there is no NHS tariff)
 
Cost Savings Calculation
Assuming the following:
  1. Adult Population of the England is Approx. 45 million
  2. BLF figure show approx. 10% of population suffers from OSA = 4.5 million
  3. DH figures show that approx. 30% of adult population has Hypertension = 13.5 million
  4. Public Health England shows that 1.3 million people have Atrial Fibrillation
 
The cost of referring 1% of the above population to hospital annually, will cost approximately:
  1. OSA – 45,000 £32 million per year.
  2. Hypertension – 135,000 £79 million per year
  3. AF – 13,000 £10.5 million per year
 
Total cost of £121.5 million
Cost of S-Med Service - £38.6 million
Savings to NHS = £83 million per year.
 
Aside from OSA, this equipment can be used for chronic heart conditions studies as well as more longitudinal studies adding a wealth of data for clinicians to inform them of patient’s conditions at work, rest and play without the equipment being intrusive and disturbing as current cuff based systems thereby removing the abnormal results they can provide. Thus, this equipment may also be of benefit to clinical trial units or during treatment to monitor the physiological effects experienced by patients undergoing a drug or other clinical interventions. 
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
In addition to patients getting a faster diagnosis, it will reduce the burdens on NHS Trusts not only from the reduction on 1st line referrals to hospitals, but from patients conditions deteriorating, or suffering economic or social problems waiting 6 months for a diagnosis and treatment to be considered.

North West Innovation Agency (AHSN) will be conducting a pilot which will monitor 75 patients via a number of GP’s Practices. Results should be available by the End of February 2018.
As a West Midlands based company we would welcome an opportunity to work with NHS Trusts and CCG’s within the region to help us grow this service within the UK for the NHS and to increase our team to service and facilitate such requirements.  
Current and planned activity: 
Current NHS engagement
  • Embarking on a NIA application with North West Innovation Agency
  • Submitted an application into the ITP based on experience and adoption within the NWIA area.
  • Considering a NIHR project following a meeting at AHSN meeting - Speaking with West Midlands NIHR/CRN
Requested NHS engagement
  • Procurement / Adoption of: -  Would welcome assistance to gain greater Adoption by Trusts and CCGs within the West Midlands
     
  • Evaluation / Validation / Clinical Trial – Interested in trials for use of our ambulatory equipment (SOMNOtouch) within new clinical areas to show its versatility and extend its clinical use to provide validated evidence within in these new areas.
     
  • Project Assistance S-Med is interested in locating potential clinical / academic collaborators to engage in their current work and to explore other clinical applications of their technology.
What is the intellectual property status of your innovation?:
Device IP held by SOMNOmedics Germany. Clinical diagnostic and reporting service is owned by S-Med Ltd.
Reg. CE0494
We have obtained IGSoC Level 2 (ODS Code: 8JP12)
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
2 years
Ease of scalability: 
3
Read more
Hide details
Selwyn Sher 03/10/2017 - 12:27 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
eCAS Card simplifies recording activity data at point of care in busy A&E Departs.  This data is available to all clinical staff with associated patient safety checks. Patient record is more complete accurately reflecting activity & improving coding
Overview of Innovation:
Paperlite - The eCAS Card system is a replacement for the paper Casualty Card used in an Accident & Emergency Department and focuses on simplifying activity recording so the patient record contains rich clinical and nursing content. 
 
Data Collection – The eCAS Card system simplifies and streamlines data collection by reflecting the processes and work flow within A&E Departments whilst integrating with the Trust’s PAS and key IT systems to ensure administrative functions are minimised.
 
Accessibility - No longer are nurses and clinicians required to search for a single paper record as they will have access to the latest patient information anywhere within the hospital where there is browser access to the network.  The same patient record can be viewed with the capability of updating different parts of the record by multiple people simultaneously.
 
Accessible via multiple devices including Tablets, iPADs and C.O.Ws utilising NHS security protocols.
 
Monitoring - the system monitors “wait times” and provides simple, visual updates on screen to assist with meeting targets.  Utilising the data provided by nursing staff, Sepsis, VTE, Child and adult safeguarding checks are undertaken and appropriate alerts raised if the data meets certain parameters.
 
  • nursing staff report that their capacity to treat patients and record their activity increases with the use of the eCAS Card service
  • clinicians benefit from having the latest patient information to ensure appropriate and timely treatment.
  • administrative staff note a significant reduction in time spent chasing paper notes, scanning CAS Cards and completing activity data not entered prior to discharge.
 
Data Sharing – the eCAS Card service ensures accurate and complete activity recording that results in an improved patient record which is then used for;
  • automatic production and e-mailing of GP attendance letters
  • all necessary reports and correspondence
  • A&E data available for Inpatient episode where a patient is admitted
  • simplified coding
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Wealth creation / Digital health / Person centred care
Benefit to NHS:
The use of eCAS Card system improves patient care, efficiency, and improves activity reporting by:

Patient Care
  • Improved patient flow facilitates quicker turnaround
  • Ensures that the right care is delivered as the clinical staff has the most up to date information at hand
  • Sepsis Screening, VTE, Child and adult safeguarding checks removes the potential for a condition/issue to be overlooked  
  • Accurate record keeping ensures episode details can be relied upon for any follow-up treatment and as part of the patient’s medical history.
Provides Efficiency
  • Increase in productivity from nursing staff who are able to Triage and stream patients quicker.
  • Information can be accesses by the clinical staff via a mobile device reducing time locating the patient record or the correct form to complete.
  • Removes the necessity for double entry and transcription errors this can cause.
  • Reduction in administrative tasks, including scanning of paper Casualty Cards, production and postage of Attendance Letters
  • Facilitates direct communication and documentation with patients GP’s
  • Interfaces with PAS and Ambulance information systems for seamless transfer of patients
  • Integrated with Referral Management services to allow for the Demand Management to ensure patient is treated in the most appropriate location by the optimum service
  • Key step in becoming a paper-lite NHS organisation
 
Improved Data Quality
  • Improved recording of activity to allow for more accurate charging and ensuring the Trust is paid for all its activity and improves CQUIN Reporting
  • Outputs audit data for department requirements and allows for the management of A&E Services based on accurate, up-to-the-minute information.
  • Integration with Primary Care to share patient data
  • Integration with Secondary Care to maintain Care Pathway if an attendance leads to an admission
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Patient Benefits
  • Improved patient experiences at A&E
  • Streamlined and efficient patient triage & treatment delivery via clear trust pathways reducing time in department
  • Consistent level of service and treatment
  • Safeguarding and inbuilt alerts for Sepsis and VTE ensures important checks are not missed
  • Reduced anxiety as clinical and nursing staff do not need to ask the same question multiple times
  • Greater confidence in the service as professionals have the information they require
  • Improved communication allows for seamless follow-up care if required
 
Trust Benefits
  • Most efficient use of resources including physical locations, equipment, staff, patient information etc.
  • Improved data collection for each episode ensures patient data is both complete and accurate, increasing confidence in nursing care and clinical decisions
  • Activity accurately recorded improving CQUIN reporting and ensuring all attendances are correctly charged
  • Clear management and audit data to allow for proactive management of the A&E Department and assessment of process efficiency.
 
Regional Benefits
  • Opportunities to manage demand of urgent care services by sharing load across Healthcare Economy as part of Sustainability & Transformation Plan.
  • Significant Patient Safety benefits by being able to consistently monitor and review vulnerable children and adults across the region.
Current and planned activity: 
Current Activity
eCAS Card used successfully by East Kent Hospital University NHS Foundation Trust since 2015.

WASP has developed additional innovative products and services for other NHS Trusts, inc. London North West Healthcare & Northampton General Hospital NHS Trusts.

WASP is undertaking  Marketing Campaign to raise awareness of products and services that support improved operational efficiency of trusts, but which can be tailored to meet the demands of STPs & Local Digital Roadmaps.

Planned Activity
  • Promotion - Meet with region’s senior managers involved with Local Digital Roadmaps to raise awareness of WASP’s current capability & strategic ambitions.
  • Adoption - Additional adoption sites within the West Midlands for the eCAS Card service.
  • Innovation –Work with an Healthcare Economy in order to implement new technology to join up the patient, GP, OOH services, NHS 111, CCG and Acute Trust providers to co-ordinate & manage Urgent & Emergency Care services demand.
  • Resolve the issues below.
What is the intellectual property status of your innovation?:
The eCAS Card Service has been specified, developed and supported by WASP Software.  The software “Code Base” is managed by the WASP Development Team and released in compiled form through our Operations Team.
On this basis, all Intellectual Property and copyright (although not registered) resides with WASP.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
3
Read more
Hide details
Michael Brett 12/09/2017 - 15:37 Publish 1 comment
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Sometimes it’s hard to prove impact. Risk Tracker helps organisations providing preventative services to record their work & demonstrate success. Provided free for anyone to use (under open license) Risk Tracker is for use on desktop & mobile devices
Overview of Innovation:
Risk Tracker is a powerful tool for managing clients and demonstrating outcomes. Designed to record information without getting in the way of the service you provide, it requires collection of a minimal amount of information from clients, but provides you with the flexibility to customise.
 
One of the key challenges for organisations who provide preventative services is connecting your clients’ progress with the complex range of National Outcome Frameworks. Inside Outcomes continuously maintains the policy environment to ensure that your reports will always reflect the most recent National Outcome Frameworks and, as the Frameworks evolve, we keep you up to date with the impact this will have on your day-to-day operation.
 
We have collated a database of issues that are common to preventative services. The system has been designed to support care navigation services by providing a quick tool to record client notes, measure outcomes and store files.
 
The Inside Outcomes Risk Tracker tool helps organisations to:
  • Record the common issues that clients present to services
  • Measure changes in those issues over time
  • Demonstrate the impact organisations have had in an evidence based way
  • Measure the impact organisations have had against National Outcome Frameworks
We have created a series of custom Risk Maps that reflect the issues clients commonly report, and aligned them with the public health life course. These Risk Maps cover diverse issues such as financial planning, housing and wellbeing, because we know the complexity of individual circumstances has an impact on your ability to provide services.

Our Risk Maps cover: We are also able to tailor risk maps to reflect service specific needs such as:-  
We also provide the facility to run anonymised open data reports that highlight social need in a particular area. Because we used a standardised format for recording the issues that people present we can aggregate data across multiple agencies to create a powerful, live commissioning tool.
 
We provide Risk Tracker free for anyone to use. We provide it under an open license so that you can run it in any way you want or even adapt the code for your own uses. You can access the code repository on our Github site. You can access the Risk Tracker manual here.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Health is influenced by a range of social, environmental and economic factors which are beyond the remit of the health sector.
 
Health services, social care and housing are all focused on delivering better outcomes at lower cost to public purse and finding ways of improving the effectiveness and better understanding the value of preventative services.
 
Risk Tracker measures the impact of organisations against national outcome frameworks, supporting them to translate the things they do into the outcomes that commissioning bodies are measured against.
 
Commissioners need to identify what services are required to deliver improvements in the prevention, diagnosis and treatment of physical and mental illness in their local population, Risk Tracker provides important data to identify top priorities and opportunities for transformation.
 
It helps commissioners to identify sub groups within their population and consider service requirements across the system, creating the person-centred services patients want and need.
 
Risk Tracker is a useful tool for analysing population data and identifying those who would gain most from the services and interventions being considered, commissioners then use this information to plan, deliver and monitor services for their local population.
 
When contracting for services, commissioners are looking for positive social outcomes, which have a lasting impact with benefits for patients that can be clearly demonstrated.
 
With Risk Tracker, information is used to improve services and influence commissioning decisions. Through recording client issues in a common format Risk Tracker allows the outcomes from disparate services to be compared and contrasted. For example, the cross over in issues that the clients present to substance misuse services, mental health services and housing associations mean that data can be aggregated together.

As all data is stored in a single, secure, compartmentalised system we can create aggregated, anonymised maps of social need. The live data that can be produced records social need and is an essential tool in commissioning services against evidenced social need.
 
Investing in prevention and better health outcomes can be part of the solution to the challenges of increasing levels of need along with shrinking budgets. Effective preventative interventions can reduce health and social care costs and the need for welfare benefits. Better health can also enhance resilience, employment and social outcomes.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Risk Tracker helps commissioners to plan services which meet national standards and local ambitions, by combining knowledge of existing service performance and population needs.
 
Commissioners traditionally do not have access to live local data. Having the ability to extract accurate data on health and wellbeing needs for a particular area supports a flexible approach to commissioning against need.
 
The methodology that underpins our system encourages services to carry out a whole person assessment.  This means exploring the range of issues that might be present in an individual’s life. Through identifying a range of interdependent issues, services can integrate how they work around an individual and improve their outcomes.
 
An important component of planning for transformation is recognising where services may
need to be decommissioned. Risk Tracker can help to identify where less effective approaches to service delivery are to be found. With a good understanding of how a service is currently operating commissioners can identify potential opportunities for innovation and improvement.
 
With Risk Tracker commissioners can develop service specifications that focus on paying for services which produce improved outcomes for their patients, rather than reimbursing providers for activity.
 
Risk Tracker will provide commissioners with the information they need to develop a vision of future service provision that will improve the health & wellbeing of individuals and communities in the West Midlands.
 
We provide Risk Tracker free for anyone to use. We provide it under an open license so that you can run it in any way you want or even adapt the code for your own uses. You can access the code repository on our Github site. You can access the Risk Tracker manual here.
Current and planned activity: 
Risk Tracker is a cloud based system & is constantly going through development as services identify new functions. We are currently exploring developing risk maps to support refugees & asylum seekers, people with disabilities, carers & suicide prevention.

Our next significant software release will incorporate individual access to records & the ability for clients to move their records from one agency to another. We believe that a person-centred approach to improving health & wellbeing requires the ability for individuals to manage their own records.
 
We would like WMAHSN to help to scale up Risk Tracker across the WM region. It is provided free of charge under an open license & users can run it in any way they want, even adapt the code for their own uses. By using WMAHSN’s network to promote this opportunity, WM commissioners can develop service specifications that focus on paying for services which produce improved outcomes for patients rather than reimbursing providers for activity.
What is the intellectual property status of your innovation?:
Inside Outcomes own the full IP for the product but release it for use under an open source license. 
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Regional Scalability:
The Risk Tracker system has been built to be delpoyed at scale. The system can manage an unlimited number of organisations, and projects within organisations. The platform the system is built on is designed to dynamically utilise server capacity in line with the number of organsations using it. 
Measures:
The prinicple outcome we are aiming for is to be able to produce live data on social need for an area. 
Adoption target:
We are looking at opportunities to support neighbourhood working in line with strategic objectives of the West Midlands Combined Authority. The Risk Tracker system has been designed to set a basis for metrics in disaparate organisations and be used to integrate services using a common format of data collection. 
Read more
Hide details
Darren Wright 05/09/2017 - 15:35 Detailed Submission Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Our expert people and advanced health analytics reveal insights from complex data that enable health & care professionals working across the West Midlands to make better decisions for the patients and populations they serve.
Overview of Innovation:
Sollis and the world-renowned Johns Hopkins University have collaborated to produce a population health analytics platform that helps health & care professionals transform services for patients and populations.
 
Sollis Clarity and The Johns Hopkins  ACG ®System is a person-focused case-mix system that captures the multi-dimensional nature of an individual’s health. It considers the total disease experience of each patient, including the implications of co-occurring disease, encouraging a holistic view of the patient rather than the management of specific diseases or episodes.
 
Sollis Clarity supports:
  • Case Finding - Patient level risk stratification
  • Resource Management - Case-mix risk adjustment and benchmarking
  • Population Health Needs Assessment - Population level risk stratification
  • Fair Shares Budgeting - Capitated budget setting
 
Sollis Clarity delivers robust business analytics and data management to identify and analyse populations across the continuum of care to help health & care providers and commissioners get a precise understanding of patterns of mult-morbidity across populations and its relationship to utilisation, costs and outcomes.
 
Sollis Clarity delivers insights into the morbidity patterns of different populations, supporting population health management, service transformation, integrated care and, ultimately, better outcomes for patients.
 
Sollis Clarity goes beyond patient level risk stratification. Risk stratification at a population level helps the health economy — providers and commissioners — analyse and minimise the progression of diseases and the exacerbation of co-morbidities. When combined with the ACG System it is a comprehensive family of measurement tools designed to help explain and predict how healthcare resources are delivered and consumed.
 
Sollis Clarity provides the evidence base to support:
  • Planning and service re-design
  • Clinical decision making
  • Outcomes-based commissioning
  • Risk stratification and predictive modelling
  • Population profiling / segmentation
  • Case-mix adjusted benchmarking
  • Integrated multi-disciplinary care
To view Sollis - Nigel's Story - click here.
To view UK Healthcare data analytics for NHS CCGs - click here.
To view The Proactive Care at Brighton & Hove - click here.
To view Population Profiling at NHS Slough CCG - click here.
To view Using Data to Gain Greater Insight - click here.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wealth creation / Digital health
Benefit to NHS:
Population health analytics delivers an evidence base (insights from data) that supports large scale health & care service transformation. It is an essential component of any Population Health Management strategy and as such underpins the journey to a fully fledged Accountable Care System (ACS).

The Sollis Clarity health analytics platform is a modular system with mix-and-match components to help you achieve your healthcare analysis and commissioning/budgeting requirements.
 
Population health management helps Health & Care stakeholders identify and quantify the drivers and outcomes for addressing the needs of local populations.
 
Led by directors with decades of NHS experience, Sollis analytics software and professional services have been used to analyse data on nearly half the population of England. We believe patient-centred care strategies based on the needs of local populations provide the key to better population health management.
 
Sollis Clarity is helping several CCGs in the UK to implement new reporting and service planning initiatives.  To view examples of ‘Service Transformation: Stories from the CCG Frontline’ summarising how CCGs are using the insights provided by Clarity Patients and ACG® System analysis for service planning and transformation – click here.
 
The Sollis Clarity health analytics platform has two distinct but complementary solutions — Clarity Patients and Clarity Finance — address population health management and financial analysis respectively.
 
Clarity Patients, combined with the Johns Hopkins ACG® System, provides a comprehensive family of measurement tools that helps explain how healthcare resources are delivered and consumed. It supports new commissioning models such as Commissioning for Value, Outcomes Based Commissioning and Year‑of‑Care Commissioning. It delivers analytics that provide insights to support health & care interventions and innovation and it will help you track the success — or otherwise — of those innovations over time.
 
Clarity Finance provides contract management and activity costing with multiple tariffs, giving you business critical evidence on which to base commissioning decisions. It enables you to store and compare different versions of cost and volume type tariffs as well as non-activity tariffs, such as year of care or outcome based currencies, to give you insights on the most effective commissioning decisions.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Knowledge of the risk profile of the region’s population (based around a population segmentation approach) will help Health & Care stakeholders across the West Midlands commission and deliver appropriate preventative services that will drive positive health outcomes for the 'at need' populations of the West Midlands. 

Through the innovative use of information technology to identify patients most in need of an intervention (impactable patient cohorts) Sollis Clarity helps to identify patients who could most benefit from earlier, better informed health care interventions.
 
The Sollis population health analytics platform allows the patient population to be risk assessed to provide timely, evidential data to all members of a Multi-Disciplinary Team (MDT), to include clinicians but not limnited to them. This enables MDT members to provide focused levels of care to specific groups of patients, reducing the risk of a patient’s condition worsening due to it being identified early so assisting MDT members in identifying and improving the care of at-risk patients.
 
Much can be achieved through the acquisition of primary care, secondary care, community care, mental health, prescribing and social care data. It can provide a rich understanding of how healthcare resources are delivered and consumed and by whom. Such analysis can aid an understanding of whether scarce resources are being deployed to those population groups in greatest need.
 
It is important that any population health analysis should focus not on single disease conditions, but on the burden of multi-morbidity observable in a local population.  Population health programmes that have the best chance of success will be those that demonstrate an understanding of the importance of multi-morbidity and its impact on the local health and care economy.
 
Using data to identify early healthcare interventions can provide significant benefits to patients, particularly those with long-term conditions. Providing the functionality to make real time decisions based on clinical evidence will improve outcomes for patients.
 
Sollis exist to help our customers deliver better patient outcomes, better patient experiences at an affordable cost and are wholly focused on the delivery of insights that will help deliver a sustainable and transformed health and care system in the West Midlands.
Current and planned activity: 
We are currently providing analytics support to thirty (30) plus Clinical Commissioning Groups (CCGs) nationally as well as nine hundred (900) plus GP practices and a number of NHS Vanguards, principally Multispecialty Community Providers (MCPs).

We would like to engage with health and care professionals involved in the development and evaluation of New Care Models throughout the West Midlands who want to use evidence based data to understand patterns of multi-morbidity and its relationship to utilisation, costs and outcomes. We are particularly interested in engaging with Sustainability & Transformation Paernerships (STPs) and emerging Accountable Care Systems (ACS).
What is the intellectual property status of your innovation?:
Sollis owns all Intellectual Property (IP) for the following software applications:
  • Sollis Clarity (Population Analytics Platform)
  • Sollis Clarity Patients
  • Sollis Clarity Finance
 Johns Hopkins Health Care (JHHC) owns all Intellectual Property (IP) for the following software:
  • ACG® System
 Also:
  • ISO9001
  • IG Toolkit Certified
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
3 years +
Ease of scalability: 
2
Read more
Hide details
Nigel Slone 21/08/2017 - 10:53 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Achiever Medical LIMS helps research institutions to improve lab efficiency, facilitates return on investment into sample collections & demonstrates compliance to legislation. Inbuilt security protects patient identifiable data with controlled access
Overview of Innovation:
With increasingly stringent regulations and greater emphasis on profitability placed on laboratories, Achiever Medical LIMS was designed in conjunction with leading scientists & clinicians to provide an easy-to-use sample management system incorporating sample tracking, clinical data management, workload & communication management. The system addresses the gap left by traditional LIMS systems by providing enhanced donor and research profile data.
 
Achiever Medical LIMS is a process driven & web browser-based laboratory & clinical data management system that is flexible/scalable to evolve as needs develop. Using Open Standards to streamline the sharing of information across existing applications Achiever Medical LIMS allows data to be imported from, e.g. Patient Information & Storage Environment Management Systems, Lab equipment, Emails & Calendars for an holistic overview of samples, equipment, environment & workload.
 
Achiever Medical LIMS enables the mapping of Standard Operating Procedures (SOP) to ensure staff adhere to agreed standards, ensuring regulatory compliance & promoting quality, efficiency & consistency. Achiever Medical LIMS can assist in compliance with the Human Tissue Act, Good Laboratory Practice & CFR 21 Part 11.
 
Sample tracking functionality delivers complete traceability with automatic generation of unique reference numbers for each sample. Core sample details e.g. location/sample type are tracked as values change for a complete audit history. Sample profile information is captured including sample & tissue type, tissue collection details and associated patient & project information. Barcode labels can be generated for single/multiple samples & customised information can be contained within each label. These labels can be scanned to facilitate rapid sample retrieval.
 
Achiever Medical LIMS integrates data and processes across multiple faculties/diverse into a single solution. This enables authorised users to gain an holistic oversight, having full access to complete donor/patient records. Robust security filters and flexible tools within the LIMS allow the creation of custom levels of user security access to samples, donors or project information. This flexibility is especially useful for biobank or bio-repository management or when conducting multiple studies/clinical trials/projects with multiple collaborators. These tools support collaborative working and simplify a task that can otherwise be legislatively difficult and time-consuming.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Advanced diagnostics, genomics and precision medicine / Clinical trials and evidence / Digital health
Benefit to NHS:
Achiever’s LIMS ability to quickly and efficiently organise samples for tracking, storage and retrieval, enables the full economic and scientific value of existing samples to be effectively realised and more efficient processing of sample requests and tests.
 
Achiever Medical LIMS enables sample aliquots to be easily generated from the parent record for complete traceability with a sample ‘family history’ view available, from both the parent & child records, allowing rapid navigation between samples within the same family.
 
Tools to enable the detailed tracking & monitoring of a sample via comprehensive sample location & check in/out auditing are provided. These include recording each time the sample is removed from its location, who checked it out and for what purpose. Samples that have been ‘checked out’ are easily identifiable and can be quickly ‘checked in’ when required along with their full audit trail information.
 
Samples used and associated stock depletion during testing or analyses are automatically flagged with Achiever Medical LIMS.
 
Composite samples such as Tissue Microarrays can be easily created within Achiever Medical LIMS, with each individual sample’s position within the composite sample recorded, any requests for removal can be easily and effectively managed.
 
External sample requests received by biobanks & bio-repositories can be managed through Achiever Medical LIMS using its built in management protocols. This facility provides staff with complete chain of custody details for each sample ((the person who requested the sample, reason for request, who approved the request & expected return date (if required) are captured)). Rejected requests are appropriately managed with reasons for rejection being recorded. Where only part of the sample is required, aliquots can be generated for the required amount along with accompanying complete family history record. Dashboards highlight samples due for return, allowing staff to monitor/chase up samples where required.
 
Achiever’s complete sample auditing & sample tracking functionality records changes by staff to core sample information. Audit trail information includes details of specific information fields changed, values pre & post change, date, time and name of the user who made the change etc. Chain of Custody details, including who checked in the sample, to whom it is checked out (where relevant), storage location, details of processing and projects included in are also captured.
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
The West Midlands population has access to the most extensive range of specialist tests from a range of stakeholders, showcasing the potential of laboratory contributions to raise the profile of the research, clinical and diagnostic expertise of the region’s NHS laboratory staff.
 
For laboratories, biobanks and bio-repositories sample tracking & donor management capabilities are of huge importance in donor profiling, consent management, traceability, chain of custody & regulatory compliance.
 
The integration of a potentially region-wide system to manage tissue tracking across multiple teams, hospitals and sites can avoid duplication of data entry and maximise data quality while working within the IT and legislative constraints imposed by disparate working environments of the users.
 
Having sought approval for sample collection, samples need to be treated in line with SOPs and available for use in research both internally and with permitted collaborators.  Utilisation of samples is important to maximise the potential benefit from the donor and to make best use of the resources available to clinicians and researchers.  Cost recovery models allow for income generation to promote the sustainability of the biobank.
 
Improving the value of data quality enables laboratory staff and researchers to search for tissue samples from specific cohorts of donors, filtering by level of consent given by donors, allowing them to search for tissues that have not opted out of specific elements of research. This level of capability will allow biobanks and bio-repositories to service very specialist research requests, increasing value.
 
The quality of the donor, consent, storage and tissue viability data greatly increases the value of the tissues to laboratory staff and researchers. Once cleansed, Achiever Medical LIMS’s storage management capabilities help to increase levels of utilisation, reducing overhead costs per sample.
 
The ‘Achiever Medical Researcher Portal’ allows authorised collaborators to view restricted data for relevant samples.  This external view portal promotes the management of sample requests all within a single system, giving an easy means of sharing samples and the relevant data.  Automatic alerts ensure applications are managed efficiently.
 
In addition, reports and analysis providing real-time data, can be run at the touch of a button instead of valuable laboratory personnel spending days (sometimes weeks) painstakingly collating information from various spreadsheets.
Current and planned activity: 
We are a West Midlands based company wishing to work with our regional health providers.  
 
Our current users include Leeds (LTHT), Nottingham (NUH) and Cambridge (CUH) Trusts all of whom use the system to manage their research samples, donor data and to support HTA Audits.
 
Both NUH and CUH use Achiever Medical as part of their involvement with GEL.
 
Achiever Medical is being used to pioneer the data standards being promoted by UKCRC.
 
We would like to work with WMAHSN who are leading the collaboration of The West Midlands Genomic Medicine Centre (WMGMC), a partnership of 18 NHS Acute Trusts across the region, working collaboratively to help to deliver the UK 100,000 Genomes Project.   
We would welcome the opportunity to discuss any requirements for sample management and donor management, projects and disease specific systems for either single organisations or multi-institutional requirements.
What is the intellectual property status of your innovation?:
All IP is owned by Interactive Software Limited.
Return on Investment (£ Value): 
medium
Return on Investment (Timescale): 
2 years
Ease of scalability: 
Simple
Read more
Hide details
Sandie Shokar 01/08/2017 - 08:19 Publish 2 comments
0
0
Votes
-99999

Recent Activities

Ravi Kumar commented on Continuing Healthcare Workflow Software: CHC2DST to underpin service transformation 5 weeks 2 days ago
Clinical Research and Clinical Trial Collaborations has been moved from Initial Submission to Publish 5 weeks 3 days ago
Chris Dyke commented on Discharge Accelerator 5 weeks 4 days ago
Discharge Accelerator has been moved from Initial Submission to Publish 9 weeks 4 days ago
Ravi Kumar commented on Cera Care 9 weeks 6 days ago

Active Campaigns